Activity

Immune therapy is the future of non-invasive cancer treatment!

NICE U-turn brings breakthrough immunotherapy to kidney cancer patients in UK – Medical News Today

http://www.medicalnewstoday.com/releases/313655.php

Bristol-Myers Squibb has announced that its breakthrough medicine Opdivo® (nivolumab) will be available from today (21 October) to NHS patients in England and Wales who have the most…

Yes! Immuno therapy approved for first line treatment is a huge step! Now patients can go for the least invasive treatments first. instead of having to go through the decades old toxic chemos before qualifying for immune therapy.

CRI – Checkpoint Immunotherapy Combination Approved for First-line Treatment of Advanced Kidney Cancer

https://www.cancerresearch.org/blog/april-2018/fda-approval-rcc-combination-checkpoint-therapy?utm_source=luminate&utm_medium=email&utm_campaign=cancerimmunews&utm_content=may2018

The combination of checkpoint immunotherapies against PD-1 and CTLA-4 significantly improved survival and response rates compared to chemotherapy in a phase III clinical trial.

Immune therapy is the future of non-invasive cancer treatment!

NICE U-turn brings breakthrough immunotherapy to kidney cancer patients in UK – Medical News Today

http://www.medicalnewstoday.com/releases/313655.php

Bristol-Myers Squibb has announced that its breakthrough medicine Opdivo® (nivolumab) will be available from today (21 October) to NHS patients in England and Wales who have the most…

http://www.medicalnewstoday.com/releases/310777.php